Genitourinary Cancer

MD IQ

How I will treat my next patient

Is it time to expand the use of PARP inhibitors?

Dr. Alan P. Lyss breaks down new findings presented at the European Society of Medical Oncology Congress on the expanded use of PARP inhibitors in...

Conference Coverage

PARP inhibitor prolongs PFS in mCRPC

BARCELONA – The PROfound trial shows that targeted therapy can be effective against metastatic castration-resistant prostate cancer bearing DNA...

Pages